drugset / Trial / NCT00003602

Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia

NCT00003602

Phase 3 Unknown 400 enrolled Riverside Haematology Group
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. It is not yet known which combination chemotherapy regimen is more effective in treating older patients with acute myeloid leukemia. PURPOSE: Randomized phase III trial to compare the effectiveness of two different combination chemotherapy regimens in treating older patients with acute myeloid leukemia in first remission.

Timeline

Start
1998-03
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cytarabine Small molecule Intravenous
Subject Etoposide Small molecule Intravenous
Subject Idarubicin Small molecule Intravenous
Subject Mitoxantrone Small molecule Intravenous